NCT01121471View on ClinicalTrials.gov

Supplementation With Conjugated Linoleic Acid (CLA) as Complementary Therapy in the Management of Type 2 Diabetes Mellitus (Women's Diabetes Study)

NACompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions
Diabetes Mellitus
Interventions
DIETARY_SUPPLEMENT

Conjugated Linoleic Acid (CLA)

6.4 g CLA/day, capsule form, for 16 week arms

DIETARY_SUPPLEMENT

Safflower OIl

8.0g/day safflower oil

Trial Locations (1)

43210

The Ohio State University, Columbus

Sponsors

Collaborators (1)

Cognis
All Listed Sponsors
collaborator

Cognis

INDUSTRY

lead

Ohio State University

OTHER

NCT01121471 - Supplementation With Conjugated Linoleic Acid (CLA) as Complementary Therapy in the Management of Type 2 Diabetes Mellitus (Women's Diabetes Study) | Biotech Hunter | Biotech Hunter